LENZ Therapeutics, Inc. LENZ
3.50 USD +0.49 (+16.28%)
At closeNov 6, 2026, 4:20 PM EST
3.50 0.00 0.00%
After hours · Nov 6, 4:20 PM ET
3.00 Day range 3.51
3.01 52-week range 31.94
- YTD
- -78.13%
- 1 year
- -84.76%
Financial health
Altman Z-Score
0.41 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Rating
B3 / 5 overall
- DCF 3
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 5
- P/E 1
- P/B 5
Valuation
P/E -5.6×
FY 2019 5y median -5.6× FY 2025
P/S 24.2×
FY 2019 5y median 0.0× FY 2025
P/B 1.6×
FY 2019 5y median -1.1× FY 2025
P/FCF -6.6×
FY 2019 5y median -6.6× FY 2025
EV/EBITDA -5.4×
FY 2019 5y median -6.7× FY 2025
EV/Sales 22.9×
FY 2019 5y median 0.0× FY 2025
FCF Yield -15.2%
FY 2019 5y median -15.2% FY 2025
Profitability
Gross Margin 96.3%
FY 2019 5y median 0.0% FY 2025
Operating Margin -477.5%
FY 2019 5y median 0.0% FY 2025
Net Margin -430.3%
FY 2019 5y median 0.0% FY 2025
ROE -28.9%
FY 2019 5y median 44.7% FY 2025
ROIC -32.0%
FY 2019 5y median -32.0% FY 2025
ROA -26.8%
FY 2019 5y median -26.8% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2019 FY 2025
Operating Income -55.5%
FY 2019 FY 2025
EPS (diluted) -21.8%
FY 2019 FY 2025
Free Cash Flow -16.9%
FY 2019 FY 2025
Financial Health
Current Ratio 14.2×
FY 2019 5y median 14.2× FY 2025
Quick Ratio 14.2×
FY 2019 5y median 14.2× FY 2025
Debt / Equity 0.0×
FY 2019 5y median 0.0× FY 2025
Net Debt / EBITDA 0.3×
FY 2019 5y median 0.4× FY 2025
Interest Coverage 0.0×
FY 2019 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31